Literature DB >> 1532221

Down syndrome and leukemia.

L L Robison1.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1532221

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  10 in total

1.  Excellent long-term survival of children with Down syndrome and standard-risk ALL: a report from the Children's Oncology Group.

Authors:  Yousif Matloub; Karen R Rabin; Lingyun Ji; Meenakshi Devidas; Johann Hitzler; Xinxin Xu; Bruce C Bostrom; Linda C Stork; Naomi Winick; Julie M Gastier-Foster; Nyla A Heerema; Eileen Stonerock; William L Carroll; Stephen P Hunger; Paul S Gaynon
Journal:  Blood Adv       Date:  2019-06-11

2.  Immune-related conditions and acute leukemia in children with Down syndrome: a Children's Oncology Group report.

Authors:  Amy M Linabery; Wenchao Li; Michelle A Roesler; Logan G Spector; Alan S Gamis; Andrew F Olshan; Nyla A Heerema; Julie A Ross
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12-10       Impact factor: 4.254

Review 3.  Cancer burden and trends in the Asian Pacific Rim region.

Authors:  Binh H Yang; D Maxwell Parkin; Lin Cai; Zuo Feng Zhang
Journal:  Asian Pac J Cancer Prev       Date:  2004 Apr-Jun

4.  Congenital abnormalities and acute leukemia among children with Down syndrome: a Children's Oncology Group study.

Authors:  Amy M Linabery; Cindy K Blair; Alan S Gamis; Andrew F Olshan; Nyla A Heerema; Julie A Ross
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09-30       Impact factor: 4.254

5.  Pediatric acute lymphoblastic leukemia and exposure to pesticides.

Authors:  Offie P Soldin; Hala Nsouli-Maktabi; Hala Nsouly-Maktabi; Jeanine M Genkinger; Christopher A Loffredo; Juan Antonio Ortega-Garcia; Drew Colantino; Dana B Barr; Naomi L Luban; Aziza T Shad; David Nelson
Journal:  Ther Drug Monit       Date:  2009-08       Impact factor: 3.681

6.  Developmental differences in IFN signaling affect GATA1s-induced megakaryocyte hyperproliferation.

Authors:  Andrew J Woo; Karen Wieland; Hui Huang; Thomas E Akie; Taylor Piers; Jonghwan Kim; Alan B Cantor
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808

7.  Maternal and offspring genetic variants of AKR1C3 and the risk of childhood leukemia.

Authors:  Chen-yu Liu; Yi-Hsiang Hsu; Pi-Chen Pan; Ming-Tsang Wu; Chi-Kung Ho; Li Su; Xin Xu; Yi Li; David C Christiani
Journal:  Carcinogenesis       Date:  2008-03-13       Impact factor: 4.944

8.  Epidemiological evidence of childhood leukaemia around nuclear power plants.

Authors:  Marek K Janiak
Journal:  Dose Response       Date:  2014-02-25       Impact factor: 2.658

9.  Breastfeeding and early infection in the aetiology of childhood leukaemia in Down syndrome.

Authors:  J Flores-Lujano; M L Perez-Saldivar; E M Fuentes-Pananá; C Gorodezky; R Bernaldez-Rios; M A Del Campo-Martinez; A Martinez-Avalos; A Medina-Sanson; R Paredes-Aguilera; J De Diego-Flores Chapa; V Bolea-Murga; M C Rodriguez-Zepeda; R Rivera-Luna; M A Palomo-Colli; L Romero-Guzman; P Perez-Vera; M Alvarado-Ibarra; F Salamanca-Gómez; A Fajardo-Gutierrez; J M Mejía-Aranguré
Journal:  Br J Cancer       Date:  2009-09-01       Impact factor: 7.640

10.  Childhood and maternal infections and risk of acute leukaemia in children with Down syndrome: a report from the Children's Oncology Group.

Authors:  K N Canfield; L G Spector; L L Robison; D Lazovich; M Roesler; A F Olshan; F O Smith; N A Heerema; D R Barnard; C K Blair; J A Ross
Journal:  Br J Cancer       Date:  2004-11-29       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.